Cargando…
Niaspan inhibits diabetic retinopathy-induced vascular inflammation by downregulating the tumor necrosis factor-α pathway
Diabetic retinopathy (DR) is a serious microvascular complication of diabetes and a major cause of blindness in the developing world. Early DR is characterized by vascular neuroinflammation, cell apoptosis and breakdown of the blood-retinal barrier (BRB). However, optimal treatment options and assoc...
Autores principales: | Wang, Yang, Meng, Xiangda, Yan, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367335/ https://www.ncbi.nlm.nih.gov/pubmed/28138697 http://dx.doi.org/10.3892/mmr.2017.6146 |
Ejemplares similares
-
MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy
por: Wang, Yang, et al.
Publicado: (2016) -
Niaspan Attenuates the Adverse Effects of Bone Marrow Stromal Cell Treatment of Stroke in Type One Diabetic Rats
por: Yan, Tao, et al.
Publicado: (2013) -
Combination BMSC and Niaspan Treatment of Stroke Enhances White Matter Remodeling and Synaptic Protein Expression in Diabetic Rats
por: Ye, Xinchun, et al.
Publicado: (2013) -
Simvastatin inhibits ischemia/reperfusion injury-induced apoptosis of retinal cells via downregulation of the tumor necrosis factor-α/nuclear factor-κB pathway
por: ZHANG, YU, et al.
Publicado: (2015) -
Lupeol and stigmasterol suppress tumor angiogenesis and inhibit cholangiocarcinoma growth in mice via downregulation of tumor necrosis factor-α
por: Kangsamaksin, Thaned, et al.
Publicado: (2017)